Search Within

Vanessa Sofi Rodrik - Outmezguine

Formats
  1. Meeting Abstract (13)
  2. Journal Article (11)
Groups
  1. Sloan Kettering Institute Postdocs (24)
  2. Breast Medicine Service (22)
  3. Department of Medicine (22)
  4. GSK Faculty (22)
  5. Molecular Pharmacology and Chemistry Program Faculty (22)
  6. Sloan Kettering Institute Faculty (22)

More Groups

People
  1. Neal Rosen (22)
  2. Sarat Chandarlapaty (14)
  3. Jose Baselga (10)
  4. Elisa De Stanchina (7)
  5. Zhan Yao (7)
  6. Marie Will (6)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (3)

More Years

Publications
  1. Cancer Research (11)
  2. Cancer Cell (2)
  3. Cancer Discovery (2)
  4. European Journal of Cancer (2)
  5. Nature (2)
  6. Cell Cycle (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. Nature Publishing Group (3)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. American Association for the Advancement of Science (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS signaling
    Meeting Abstract

    Will, M.; Toy, W.; Yao, Z.; Poulikakos, P.; Rodrik-Outmezguine, V. ; Schneider, C.; Paul, J.; Baselga, J.; Liu, N.; Rosen, N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • MTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
    Journal Article

    Elkabets, M.; Vora, S.; Juric, D.; Morse, N.; Mino-Kenudson, M.; Muranen, T.; Tao, J.; Bosch Campos, A.; Rodon, J.; Ibrahim, Y. H.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Cytotoxic and cystostatic properties of rapamycin are due to differential effects on the phosphorylation of mTORC1 substrates S6 kinase and 4E-BPI
    Meeting Abstract

    Yellen, P.; Chatterjee, A.; Sagcena, M.; Salloum, D.; Preda, A.; Rodrik-Outmezguine, V.; Feng, J. N.; Xu, L. M.; Foster, D. A.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • mTOR kinase inhibition relieves feedback suppression of receptor tyrosine kinase leading to a biphasic regulation of AKT signaling in breast cancer cells
    Meeting Abstract

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Pagano, N. C.; Poulikakos, P. I.; Scaltriti, M.; Baselga, J.; Guichard, S.; Rosen, N.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Reactivation of oncogenic signaling through mTOR inhibitors-induced feedback adaptations
    Meeting Abstract

    Rodrik-Outmezguine, V.; Chandarlapaty, S.; Poulikakos, P.; Scaltriti, M.; Baselga, J.; Rosen, N.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • mTOR kinase inhibition relieves feedback inhibition of RTK and PI3K signaling in breast cancer cells
    Meeting Abstract

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Cao, N.; Smith, P.; Guichard, S.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Inhibition of PI3K-AKT signaling causes a FOXO-dependent induction of receptor tyrosine kinase expression and phosphorylation in cancer
    Meeting Abstract

    Chandarlapaty, S.; Sawai, A.; Rodrik-Outmezguine, V.; Scaltriti, M.; Serra, V.; Baselga, J.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1
    Journal Article

    Yellen, P.; Saqcena, M.; Salloum, D.; Feng, J.; Preda, A.; Xu, L.; Rodrik-Outmezguine, V. ; Foster, D. A.
    Cell Cycle (2011)

    Fulltext@MSK | Save